SSY Pharmaceutical Research Institute SSY Pharmaceutical Research Institute

Corporate email

中文/EN

简体中文

English

NEWS CENTER

Group Announcement

Media reports

Group News

Shijiazhuang Siyao Group Guolong Pharmaceutical’s bronchodilator ipratropium bromide active pharmaceutical ingredient has been approved.

Category:

Group Announcement

Time：2022-01-20

On December 28, the active pharmaceutical ingredient ipratropium bromide—a bronchodilator—submitted by Hebei Guolong Pharmaceutical Co., Ltd. of Shijiazhuang Sihua Pharmaceutical Group was approved by the National Medical Products Administration and can now be used in marketed formulations.
Shijiazhuang Siyao Group Guolong Pharmaceutical’s bronchodilator ipratropium bromide active pharmaceutical ingredient has been approved.
Shijiazhuang Siyao Group Guolong Pharmaceutical’s bronchodilator ipratropium bromide active pharmaceutical ingredient has been approved.
On December 28, the active pharmaceutical ingredient ipratropium bromide—a bronchodilator—submitted by Hebei Guolong Pharmaceutical Co., Ltd. of Shijiazhuang Sihua Pharmaceutical Group was approved by the National Medical Products Administration and can now be used in marketed formulations.
It is reported that ipratropium bromide is a bronchodilator primarily used to treat chronic obstructive pulmonary disease and asthma.
 

 

Keywords:

Previous

Shijiazhuang Sihua Pharmaceutical Group’s Guangxiang Pharmaceutical and Guolong Pharmaceutical have been recognized as demonstration enterprises for specialization, refinement, uniqueness, and innovation in Hebei Province.

Four employees from Guangxiang Pharmaceutical, part of Shijiazhuang Fourth Pharmaceutical Group, have been selected for the Provincial List of Innovative Talents in Science and Technology-based SMEs.

Next

Previous:

Shijiazhuang Sihua Pharmaceutical Group’s Guangxiang Pharmaceutical and Guolong Pharmaceutical have been recognized as demonstration enterprises for specialization, refinement, uniqueness, and innovation in Hebei Province.

Next:

Four employees from Guangxiang Pharmaceutical, part of Shijiazhuang Fourth Pharmaceutical Group, have been selected for the Provincial List of Innovative Talents in Science and Technology-based SMEs.